{"transactions":[{"id":698766,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-08-03T20:05:19.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":875,"price":2.414,"value":2112.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2026 through July 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 31, 2026."}],"balance_after":113699,"source":{"system":"sec-edgar","filing":"0001705905-26-000010","document":"form4-08032026_040815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000010/form4-08032026_040815.xml","form_type":"4"}},{"id":877044,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-27T21:10:07.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":95430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs become vested over four (4) years with 25% of the shares vesting February 26, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs become vested over four (4) years with 25% of the shares vesting February 26, 2027, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":95430,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":95430},"source":{"system":"sec-edgar","filing":"0001705905-26-000008","document":"form4-02272026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000008/form4-02272026_040203.xml","form_type":"4"}},{"id":877043,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2026-02-27T21:10:07.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":222670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable over four (4) years with 25% of the shares vesting on February 26, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, subject to the reporting person's continued service on each applicable vesting date."}],"balance_after":222670,"derivative":{"exercise_price":4.46,"expiration_date":"2036-02-26","underlying":"Common Stock, par value $0.0001","underlying_shares":222670},"source":{"system":"sec-edgar","filing":"0001705905-26-000008","document":"form4-02272026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000008/form4-02272026_040203.xml","form_type":"4"}},{"id":921538,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T21:15:42.000Z","date":"2026-02-02","kind":"exercise","planned":false,"acquired":false,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":921537,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T21:15:42.000Z","date":"2026-01-30","kind":"exercise","planned":false,"acquired":false,"shares":9275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":9275,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":9275},"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":921536,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-02-03T21:15:42.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2329,"price":5.55,"value":12925.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":112824,"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":921535,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-02-03T21:15:42.000Z","date":"2026-02-02","kind":"exercise","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":115153,"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":921534,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-02-03T21:15:42.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":5567,"price":3.07,"value":17090.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025."}],"balance_after":107378,"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":921533,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-02-03T21:15:42.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2859,"price":5.6,"value":16010.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":101811,"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":921532,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-02-03T21:15:42.000Z","date":"2026-01-30","kind":"exercise","planned":false,"acquired":true,"shares":9275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":104670,"source":{"system":"sec-edgar","filing":"0001705905-26-000006","document":"form4-02032026_040235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000006/form4-02032026_040235.xml","form_type":"4"}},{"id":927826,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-29T21:05:07.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":false,"shares":15850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":47550,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":15850},"source":{"system":"sec-edgar","filing":"0001705905-26-000004","document":"form4-01292026_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000004/form4-01292026_040101.xml","form_type":"4"}},{"id":927825,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-01-29T21:05:07.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4748,"price":6.18,"value":29342.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":95395,"source":{"system":"sec-edgar","filing":"0001705905-26-000004","document":"form4-01292026_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000004/form4-01292026_040101.xml","form_type":"4"}},{"id":927824,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-01-29T21:05:07.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":15850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":100143,"source":{"system":"sec-edgar","filing":"0001705905-26-000004","document":"form4-01292026_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000004/form4-01292026_040101.xml","form_type":"4"}},{"id":929888,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-27T12:00:04.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":29200,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":14600},"source":{"system":"sec-edgar","filing":"0001705905-26-000002","document":"form4-01272026_070101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000002/form4-01272026_070101.xml","form_type":"4"}},{"id":929887,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-01-27T12:00:04.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":4373,"price":5.5,"value":24051.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":84293,"source":{"system":"sec-edgar","filing":"0001705905-26-000002","document":"form4-01272026_070101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000002/form4-01272026_070101.xml","form_type":"4"}},{"id":929886,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2026-01-27T12:00:04.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":88666,"source":{"system":"sec-edgar","filing":"0001705905-26-000002","document":"form4-01272026_070101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170590526000002/form4-01272026_070101.xml","form_type":"4"}},{"id":1076152,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-08-04T20:05:21.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":846,"price":3.14,"value":2656.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2025 through July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2025."}],"balance_after":74066,"source":{"system":"sec-edgar","filing":"0001104659-25-073624","document":"tm2522384-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925073624/tm2522384-1_4seq1.xml","form_type":"4"}},{"id":1287205,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T01:43:47.000Z","date":"2025-02-02","kind":"exercise","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date"}],"balance_after":7775,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287204,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T01:43:47.000Z","date":"2025-02-01","kind":"exercise","planned":false,"acquired":true,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":6166},"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287203,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T01:43:47.000Z","date":"2025-01-30","kind":"exercise","planned":false,"acquired":true,"shares":9275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date"}],"balance_after":18550,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":9275},"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287202,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2316,"price":6.64,"value":15378.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":73220,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287201,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-02-02","kind":"exercise","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":75536,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287200,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1801,"price":6.64,"value":11958.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":67761,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287199,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-02-01","kind":"exercise","planned":false,"acquired":true,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":69562,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287198,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":3184,"price":5.18,"value":16493.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024."}],"balance_after":63396,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287197,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2709,"price":7,"value":18963.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":60212,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1287196,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-02-04T01:43:47.000Z","date":"2025-01-30","kind":"exercise","planned":false,"acquired":true,"shares":9275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":62921,"source":{"system":"sec-edgar","filing":"0001104659-25-008770","document":"tm255357-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925008770/tm255357-1_4seq1.xml","form_type":"4"}},{"id":1292955,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-29T02:06:36.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":63400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":63400,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":63400},"source":{"system":"sec-edgar","filing":"0001104659-25-006845","document":"tm254755-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925006845/tm254755-4_4seq1.xml","form_type":"4"}},{"id":1292954,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2025-01-29T02:06:36.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":183600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":183600,"derivative":{"exercise_price":7,"expiration_date":"2035-01-27","underlying":"Common Stock, par value $0.0001","underlying_shares":183600},"source":{"system":"sec-edgar","filing":"0001104659-25-006845","document":"tm254755-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925006845/tm254755-4_4seq1.xml","form_type":"4"}},{"id":1292953,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-29T02:06:36.000Z","date":"2025-01-25","kind":"exercise","planned":false,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":43800,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":14600},"source":{"system":"sec-edgar","filing":"0001104659-25-006845","document":"tm254755-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925006845/tm254755-4_4seq1.xml","form_type":"4"}},{"id":1292952,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-01-29T02:06:36.000Z","date":"2025-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":4264,"price":6.98,"value":29762.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":53646,"source":{"system":"sec-edgar","filing":"0001104659-25-006845","document":"tm254755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925006845/tm254755-4_4seq1.xml","form_type":"4"}},{"id":1292951,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2025-01-29T02:06:36.000Z","date":"2025-01-25","kind":"exercise","planned":false,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":57910,"source":{"system":"sec-edgar","filing":"0001104659-25-006845","document":"tm254755-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925006845/tm254755-4_4seq1.xml","form_type":"4"}},{"id":1444214,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-08-01T21:45:46.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":650,"price":5.41,"value":3516.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2024 through July 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2024."}],"balance_after":43310,"source":{"system":"sec-edgar","filing":"0001104659-24-084995","document":"tm2420669-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924084995/tm2420669-3_4seq1.xml","form_type":"4"}},{"id":1658581,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-05T23:02:17.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":false,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":15550,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0001104659-24-010780","document":"tm245213-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924010780/tm245213-3_4seq1.xml","form_type":"4"}},{"id":1658580,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-05T23:02:17.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":6166,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":6166},"source":{"system":"sec-edgar","filing":"0001104659-24-010780","document":"tm245213-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924010780/tm245213-3_4seq1.xml","form_type":"4"}},{"id":1658579,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-05T23:02:17.000Z","date":"2024-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2330,"price":9.32,"value":21715.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":42660,"source":{"system":"sec-edgar","filing":"0001104659-24-010780","document":"tm245213-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924010780/tm245213-3_4seq1.xml","form_type":"4"}},{"id":1658578,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-05T23:02:17.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":44990,"source":{"system":"sec-edgar","filing":"0001104659-24-010780","document":"tm245213-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924010780/tm245213-3_4seq1.xml","form_type":"4"}},{"id":1658577,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-05T23:02:17.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1801,"price":9.88,"value":17793.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":37215,"source":{"system":"sec-edgar","filing":"0001104659-24-010780","document":"tm245213-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924010780/tm245213-3_4seq1.xml","form_type":"4"}},{"id":1658576,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-05T23:02:17.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":39016,"source":{"system":"sec-edgar","filing":"0001104659-24-010780","document":"tm245213-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924010780/tm245213-3_4seq1.xml","form_type":"4"}},{"id":1663790,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-01T23:03:25.000Z","date":"2024-01-30","kind":"exercise","planned":false,"acquired":false,"shares":9275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":27825,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":9275},"source":{"system":"sec-edgar","filing":"0001104659-24-009543","document":"tm244961-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924009543/tm244961-5_4seq1.xml","form_type":"4"}},{"id":1663789,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-01T23:03:25.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":2.69,"value":15763.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2023 through January 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2023."}],"balance_after":32850,"source":{"system":"sec-edgar","filing":"0001104659-24-009543","document":"tm244961-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924009543/tm244961-5_4seq1.xml","form_type":"4"}},{"id":1663788,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-01T23:03:25.000Z","date":"2024-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2709,"price":9.8,"value":26548.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":26990,"source":{"system":"sec-edgar","filing":"0001104659-24-009543","document":"tm244961-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924009543/tm244961-5_4seq1.xml","form_type":"4"}},{"id":1663787,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2024-02-01T23:03:25.000Z","date":"2024-01-30","kind":"exercise","planned":false,"acquired":true,"shares":9275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":29699,"source":{"system":"sec-edgar","filing":"0001104659-24-009543","document":"tm244961-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924009543/tm244961-5_4seq1.xml","form_type":"4"}},{"id":1668098,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-29T23:32:38.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":58400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":58400,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":58400},"source":{"system":"sec-edgar","filing":"0001104659-24-007863","document":"tm244341-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924007863/tm244341-5_4seq1.xml","form_type":"4"}},{"id":1668097,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2024-01-29T23:32:38.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":163200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on January 25, 2025 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":163200,"derivative":{"exercise_price":9.28,"expiration_date":"2034-01-25","underlying":"Common Stock, par value $0.0001","underlying_shares":163200},"source":{"system":"sec-edgar","filing":"0001104659-24-007863","document":"tm244341-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924007863/tm244341-5_4seq1.xml","form_type":"4"}},{"id":1817749,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2023-08-02T21:47:21.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":568,"price":2.81,"value":1596.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2023 through July 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2023."}],"balance_after":20424,"source":{"system":"sec-edgar","filing":"0001104659-23-086904","document":"tm2322669-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923086904/tm2322669-2_4seq1.xml","form_type":"4"}},{"id":2030439,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-06T21:31:34.000Z","date":"2023-02-02","kind":"exercise","acquired":false,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":23325,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0001104659-23-011214","document":"tm235551-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923011214/tm235551-3_4seq1.xml","form_type":"4"}},{"id":2030438,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2023-02-06T21:31:34.000Z","date":"2023-02-02","kind":"tax_withholding","acquired":false,"shares":2375,"price":15.04,"value":35720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":19856,"source":{"system":"sec-edgar","filing":"0001104659-23-011214","document":"tm235551-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923011214/tm235551-3_4seq1.xml","form_type":"4"}},{"id":2030437,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2023-02-06T21:31:34.000Z","date":"2023-02-02","kind":"exercise","acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":22231,"source":{"system":"sec-edgar","filing":"0001104659-23-011214","document":"tm235551-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923011214/tm235551-3_4seq1.xml","form_type":"4"}},{"id":2035675,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T22:11:14.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":12332,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":6166},"source":{"system":"sec-edgar","filing":"0001104659-23-009975","document":"tm235311-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923009975/tm235311-4_4seq1.xml","form_type":"4"}},{"id":2035674,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2023-02-02T22:11:14.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":2183,"price":13.78,"value":30081.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":14456,"source":{"system":"sec-edgar","filing":"0001104659-23-009975","document":"tm235311-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923009975/tm235311-4_4seq1.xml","form_type":"4"}},{"id":2035673,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2023-02-02T22:11:14.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":16639,"source":{"system":"sec-edgar","filing":"0001104659-23-009975","document":"tm235311-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923009975/tm235311-4_4seq1.xml","form_type":"4"}},{"id":2035672,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2023-02-02T22:11:14.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":1436,"price":10.2085,"value":14659.406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2022 through January 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2022."}],"balance_after":10473,"source":{"system":"sec-edgar","filing":"0001104659-23-009975","document":"tm235311-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923009975/tm235311-4_4seq1.xml","form_type":"4"}},{"id":2038402,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-01T22:31:51.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":37100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":37100,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":37100},"source":{"system":"sec-edgar","filing":"0001104659-23-009354","document":"tm235142-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923009354/tm235142-3_4seq1.xml","form_type":"4"}},{"id":2038401,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2023-02-01T22:31:51.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on January 30, 2024 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 30, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":105000,"derivative":{"exercise_price":12.88,"expiration_date":"2033-01-30","underlying":"Common Stock, par value $0.0001","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001104659-23-009354","document":"tm235142-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923009354/tm235142-3_4seq1.xml","form_type":"4"}},{"id":2195534,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-08-03T20:06:06.000Z","date":"2022-07-31","kind":"grant","acquired":true,"shares":732,"price":6.86,"value":5021.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2022 through July 31, 2022."}],"balance_after":9037,"source":{"system":"sec-edgar","filing":"0001104659-22-085619","document":"tm2222488-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922085619/tm2222488-2_4seq1.xml","form_type":"4"}},{"id":2214420,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":14250,"derivative":{"exercise_price":2.95,"expiration_date":"2029-03-26","underlying":"Common Stock, par value $0.0001","underlying_shares":787},"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214419,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-01","kind":"exercise","acquired":false,"shares":22963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15037,"derivative":{"exercise_price":2.95,"expiration_date":"2029-03-26","underlying":"Common Stock, par value $0.0001","underlying_shares":22963},"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214418,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-01","kind":"exercise","acquired":false,"shares":4019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":8750,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":4019},"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214417,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":10182,"price":12,"value":122184.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":8305,"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214416,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":787,"price":2.95,"value":2321.65,"ownership":{"direct":true},"balance_after":18487,"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214415,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-01","kind":"sale","acquired":false,"shares":26982,"price":12,"value":323784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":17700,"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214414,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-01","kind":"exercise","acquired":true,"shares":22963,"price":2.95,"value":67740.85,"ownership":{"direct":true},"balance_after":44682,"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2214413,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-07-05T21:15:44.000Z","date":"2022-07-01","kind":"exercise","acquired":true,"shares":4019,"price":2.6,"value":10449.4,"ownership":{"direct":true},"balance_after":21719,"source":{"system":"sec-edgar","filing":"0001104659-22-077433","document":"tm2220386-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922077433/tm2220386-1_4seq1.xml","form_type":"4"}},{"id":2218645,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-06-30T20:05:33.000Z","date":"2022-06-29","kind":"exercise","acquired":false,"shares":5462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":12769,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":5462},"source":{"system":"sec-edgar","filing":"0001104659-22-076291","document":"tm2220183-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922076291/tm2220183-1_4seq1.xml","form_type":"4"}},{"id":2218644,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-30T20:05:33.000Z","date":"2022-06-29","kind":"sale","acquired":false,"shares":5462,"price":12.0004,"value":65546.1848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.0000 to $12.0050, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":17700,"source":{"system":"sec-edgar","filing":"0001104659-22-076291","document":"tm2220183-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922076291/tm2220183-1_4seq1.xml","form_type":"4"}},{"id":2218643,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-30T20:05:33.000Z","date":"2022-06-29","kind":"exercise","acquired":true,"shares":5462,"price":2.6,"value":14201.2,"ownership":{"direct":true},"balance_after":23162,"source":{"system":"sec-edgar","filing":"0001104659-22-076291","document":"tm2220183-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922076291/tm2220183-1_4seq1.xml","form_type":"4"}},{"id":2220082,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-06-28T23:00:41.000Z","date":"2022-06-27","kind":"exercise","acquired":false,"shares":11769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":18231,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-075361","document":"tm2219797-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922075361/tm2219797-2_4seq1.xml","form_type":"4"}},{"id":2220081,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-06-28T23:00:41.000Z","date":"2022-06-27","kind":"exercise","acquired":false,"shares":25583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on January 2, 2021 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 2, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":35817,"derivative":{"exercise_price":1.9213,"expiration_date":"2030-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":61400},"source":{"system":"sec-edgar","filing":"0001104659-22-075361","document":"tm2219797-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922075361/tm2219797-2_4seq1.xml","form_type":"4"}},{"id":2220080,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-28T23:00:41.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":37352,"price":12.0008,"value":448253.8816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.0000 to $12.0250, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":17700,"source":{"system":"sec-edgar","filing":"0001104659-22-075361","document":"tm2219797-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922075361/tm2219797-2_4seq1.xml","form_type":"4"}},{"id":2220079,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-28T23:00:41.000Z","date":"2022-06-27","kind":"exercise","acquired":true,"shares":11769,"price":2.6,"value":30599.4,"ownership":{"direct":true},"balance_after":55052,"source":{"system":"sec-edgar","filing":"0001104659-22-075361","document":"tm2219797-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922075361/tm2219797-2_4seq1.xml","form_type":"4"}},{"id":2220078,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-06-28T23:00:41.000Z","date":"2022-06-27","kind":"exercise","acquired":true,"shares":25583,"price":1.9213,"value":49152.6179,"ownership":{"direct":true},"balance_after":43283,"source":{"system":"sec-edgar","filing":"0001104659-22-075361","document":"tm2219797-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922075361/tm2219797-2_4seq1.xml","form_type":"4"}},{"id":2413411,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-04T00:55:41.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":31100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":31100,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":31100},"source":{"system":"sec-edgar","filing":"0001104659-22-011517","document":"tm225504-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922011517/tm225504-1_4seq1.xml","form_type":"4"}},{"id":2413410,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2022-02-04T00:55:41.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":91600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on February 2, 2023 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 2, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":91600,"derivative":{"exercise_price":7.53,"expiration_date":"2032-02-02","underlying":"Common Stock, par value $0.0001","underlying_shares":91600},"source":{"system":"sec-edgar","filing":"0001104659-22-011517","document":"tm225504-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922011517/tm225504-1_4seq1.xml","form_type":"4"}},{"id":2413409,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-04T00:55:41.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":18498,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":6166},"source":{"system":"sec-edgar","filing":"0001104659-22-011517","document":"tm225504-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922011517/tm225504-1_4seq1.xml","form_type":"4"}},{"id":2413408,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-02-04T00:55:41.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":2183,"price":7.98,"value":17420.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs."}],"balance_after":17700,"source":{"system":"sec-edgar","filing":"0001104659-22-011517","document":"tm225504-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922011517/tm225504-1_4seq1.xml","form_type":"4"}},{"id":2413407,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-02-04T00:55:41.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."}],"balance_after":19883,"source":{"system":"sec-edgar","filing":"0001104659-22-011517","document":"tm225504-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922011517/tm225504-1_4seq1.xml","form_type":"4"}},{"id":2413406,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2022-02-04T00:55:41.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":2106,"price":6.86,"value":14447.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2021 through January 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2022."}],"balance_after":13717,"source":{"system":"sec-edgar","filing":"0001104659-22-011517","document":"tm225504-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922011517/tm225504-1_4seq1.xml","form_type":"4"}},{"id":2611339,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2021-08-06T23:00:37.000Z","date":"2021-07-31","kind":"grant","acquired":true,"shares":1750,"price":7.7095,"value":13491.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2021 through July 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2021."}],"balance_after":11611,"source":{"system":"sec-edgar","filing":"0001104659-21-101661","document":"tm2124283-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465921101661/tm2124283-1_4seq1.xml","form_type":"4"}},{"id":2881378,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-04T00:00:38.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":24664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":24664,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":24664},"source":{"system":"sec-edgar","filing":"0000899243-21-004756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924321004756/doc4.xml","form_type":"4"}},{"id":2881377,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2021-02-04T00:00:38.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2022 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":16.71,"expiration_date":"2031-02-01","underlying":"Common Stock, par value $0.0001","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-21-004756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924321004756/doc4.xml","form_type":"4"}},{"id":2881376,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2021-02-04T00:00:38.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":467,"price":12.14,"value":5669.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2020 through January 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2021."}],"balance_after":9861,"source":{"system":"sec-edgar","filing":"0000899243-21-004756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924321004756/doc4.xml","form_type":"4"}},{"id":3069370,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-08-04T22:43:14.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":3859,"price":1.46,"value":5634.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2020 through July 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 1, 2020."}],"balance_after":9394,"source":{"system":"sec-edgar","filing":"0000899243-20-021207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/doc4.xml","form_type":"4"}},{"id":3291229,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-02-05T01:15:53.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":3698,"price":1.46,"value":5399.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2019 through January 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2020."}],"balance_after":5535,"source":{"system":"sec-edgar","filing":"0000899243-20-002960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/doc4.xml","form_type":"4"}},{"id":3322464,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2020-01-03T22:06:30.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":61400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on January 2, 2021 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 2, 2021, subject to the reporting person's continued service through the applicable vesting date"}],"balance_after":61400,"derivative":{"exercise_price":1.9213,"expiration_date":"2030-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":61400},"source":{"system":"sec-edgar","filing":"0000899243-20-000286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/doc4.xml","form_type":"4"}},{"id":3576365,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-03-27T21:46:01.000Z","date":"2019-03-26","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.95,"expiration_date":"2029-03-26","underlying":"Common Stock, par value $0.0001","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0000925421-19-000135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/edgar.xml","form_type":"4"}},{"id":3703678,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T21:58:02.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001012975-19-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/edgar.xml","form_type":"4"}},{"id":3920323,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2018-05-23T21:23:56.000Z","date":"2018-05-21","kind":"exercise","acquired":false,"shares":55120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-12-05","underlying":"Common Stock, par value $0.0001","underlying_shares":55120},"source":{"system":"sec-edgar","filing":"0001012975-18-000457","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297518000457/edgar.xml","form_type":"4"}},{"id":3920322,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2018-05-23T21:23:56.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":50016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the option becomes vested and exercisable on March 1, 2019, and the aggregate unvested remaining portion will vest and become exercisable in equal monthly installments on the first day of each month over the 36-month period starting April 1, 2019."}],"balance_after":50016,"derivative":{"exercise_price":0.445,"expiration_date":"2028-05-21","underlying":"Common Stock, par value $0.0001","underlying_shares":50016},"source":{"system":"sec-edgar","filing":"0001012975-18-000457","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297518000457/edgar.xml","form_type":"4"}},{"id":3920321,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2018-05-23T21:23:56.000Z","date":"2018-05-21","kind":"exercise","acquired":true,"shares":55120,"price":0.08,"value":4409.6,"ownership":{"direct":true},"balance_after":55120,"source":{"system":"sec-edgar","filing":"0001012975-18-000457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297518000457/edgar.xml","form_type":"4"}},{"id":4036772,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2018-02-23T21:21:22.000Z","date":"2017-06-06","kind":"purchase","acquired":true,"shares":449,"price":4.42,"value":1984.58,"ownership":{"direct":false,"nature":"Shares held by spouse of Reporting Person"},"balance_after":449,"source":{"system":"sec-edgar","filing":"0001012975-18-000229","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297518000229/edgar.xml","form_type":"4"}},{"id":4201463,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (option to buy)","published_at":"2017-09-26T22:37:14.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On the first anniversary of the date of grant, 25% of the unvested portion of the option will become vested and exercisable, and the aggregate remaining unvested portion will vest and become exercisable in equal monthly installments over the 36-month period following such anniversary date."}],"balance_after":50000,"derivative":{"exercise_price":2.48,"expiration_date":"2027-09-22","underlying":"Common Stock, par value $0.0001","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001012975-17-000721","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297517000721/edgar.xml","form_type":"4"}},{"id":4329922,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:16.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":11235,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is currently exercisable to purchase 2,809 shares of Common Stock.  An additional 25% of the option will vest on each of 3/2/2018, 3/2/2019, and 3/2/2020."}],"balance_after":11235,"derivative":{"exercise_price":13.38,"expiration_date":"2026-04-07","underlying":"Common Stock, par value $0.0001","underlying_shares":11235},"source":{"system":"sec-edgar","filing":"0000899243-17-012361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012361/doc4.xml","form_type":"4"}},{"id":4329921,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:16.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":8956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is currently exercisable to purchase 4,477 shares of Common Stock.  An additional 25% of the option will vest on each of 12/3/2017 and 12/3/2018."}],"balance_after":8956,"derivative":{"exercise_price":2.59,"expiration_date":"2024-12-02","underlying":"Common Stock, par value $0.0001","underlying_shares":8956},"source":{"system":"sec-edgar","filing":"0000899243-17-012361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012361/doc4.xml","form_type":"4"}},{"id":4329920,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:16.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":8956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is currently exercisable to purchase 6,716 shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\").  The remaining portion of the option will vest on 12/4/2017."}],"balance_after":8956,"derivative":{"exercise_price":0.59,"expiration_date":"2023-12-04","underlying":"Common Stock, par value $0.0001","underlying_shares":8956},"source":{"system":"sec-edgar","filing":"0000899243-17-012361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012361/doc4.xml","form_type":"4"}},{"id":4329919,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":27160,"kind":"person","name":"Roberts M Scot","position":1,"cik":"0001705905","reported_name":"Roberts M Scot","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (option to buy)","published_at":"2017-05-09T00:37:16.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":55120,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."}],"balance_after":55120,"derivative":{"exercise_price":0.08,"exercise_date":"2017-05-04","expiration_date":"2022-12-05","underlying":"Common Stock, par value $0.0001","underlying_shares":55120},"source":{"system":"sec-edgar","filing":"0000899243-17-012361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924317012361/doc4.xml","form_type":"4"}}]}